Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A phase III randomised study comparing concomitant radiochemotherapy with cisplatin and docetaxel as induction versus consolidation treatment in patients with locally advanced unresectable non-small cell lung cancer.
Sculier JP, Lafitte JJ, Berghmans T, Meert AP, Scherpereel A, Roelandts M, Van Cutsem O, Colinet B, Bonduelle Y, Giner V, Paesmans M, Leclercq N, Van Houtte P. Sculier JP, et al. Among authors: leclercq n. Lung Cancer. 2018 Mar;117:32-37. doi: 10.1016/j.lungcan.2017.12.016. Epub 2018 Jan 31. Lung Cancer. 2018. PMID: 29496253 Clinical Trial.
A Phase III Randomized Study Comparing a Chemotherapy with Cisplatin and Etoposide to a Etoposide Regimen without Cisplatin for Patients with Extensive Small-Cell Lung Cancer.
Berghmans T, Scherpereel A, Meert AP, Giner V, Lecomte J, Lafitte JJ, Leclercq N, Paesmans M, Sculier JP; European Lung Cancer Working Party (ELCWP). Berghmans T, et al. Among authors: leclercq n. Front Oncol. 2017 Sep 19;7:217. doi: 10.3389/fonc.2017.00217. eCollection 2017. Front Oncol. 2017. PMID: 28975084 Free PMC article.
Second-line paclitaxel in non-small cell lung cancer initially treated with cisplatin: a study by the European Lung Cancer Working Party.
Berghmans T, Lafitte JJ, Lecomte J, Alexopoulos CG, Van Cutsem O, Giner V, Efremidis A, Berchier MC, Collon T, Meert AP, Scherpereel A, Ninane V, Leclercq N, Paesmans M, Sculier JP; European Lung Cancer Working Party. Berghmans T, et al. Among authors: leclercq n. Br J Cancer. 2007 Jun 4;96(11):1644-9. doi: 10.1038/sj.bjc.6603772. Epub 2007 May 1. Br J Cancer. 2007. PMID: 17473825 Free PMC article. Clinical Trial.
Chemotherapy improves low performance status lung cancer patients.
Sculier JP, Lafitte JJ, Paesmans M, Lecomte J, Alexopoulos CG, Van Cutsem O, Giner V, Efremidis A, Berchier MC, Collon T, Meert AP, Scherpereel A, Ninane V, Koumakis G, Vaslamatzis MM, Leclercq N, Berghmans T; European Lung Cancer Working Party. Sculier JP, et al. Among authors: leclercq n. Eur Respir J. 2007 Dec;30(6):1186-92. doi: 10.1183/09031936.00034507. Epub 2007 Aug 9. Eur Respir J. 2007. PMID: 17690124 Free article.
A phase III randomised study of concomitant induction radiochemotherapy testing two modalities of radiosensitisation by cisplatin (standard versus daily) for limited small-cell lung cancer.
Sculier JP, Lafitte JJ, Efremidis A, Florin MC, Lecomte J, Berchier MC, Richez M, Berghmans T, Scherpereel A, Meert AP, Koumakis G, Leclercq N, Paesmans M, Van Houtte P; European Lung Cancer Working Party (ELCWP). Sculier JP, et al. Among authors: leclercq n. Ann Oncol. 2008 Oct;19(10):1691-7. doi: 10.1093/annonc/mdn354. Epub 2008 May 25. Ann Oncol. 2008. PMID: 18504252 Free article. Clinical Trial.
A phase III randomised study comparing concomitant radiochemotherapy as induction versus consolidation treatment in patients with locally advanced unresectable non-small cell lung cancer.
Berghmans T, Van Houtte P, Paesmans M, Giner V, Lecomte J, Koumakis G, Richez M, Holbrechts S, Roelandts M, Meert AP, Alard S, Leclercq N, Sculier JP. Berghmans T, et al. Among authors: leclercq n. Lung Cancer. 2009 May;64(2):187-93. doi: 10.1016/j.lungcan.2008.08.004. Epub 2008 Sep 19. Lung Cancer. 2009. PMID: 18804894 Clinical Trial.
Final results and pharmacoeconomic analysis of a trial comparing two neoadjuvant chemotherapy (CT) regimens followed by surgery in patients with resectable non-small cell lung cancer (NSCLC): a phase II randomised study by the European Lung Cancer Working Party.
Berghmans T, Lafitte JJ, Giner V, Berchier MC, Scherpereel A, Lewin D, Paesmans M, Meert AP, Bosschaerts T, Leclercq N, Sculier JP; European Lung Cancer Working Party. Berghmans T, et al. Among authors: leclercq n. Lung Cancer. 2012 Sep;77(3):605-10. doi: 10.1016/j.lungcan.2012.04.020. Epub 2012 Jun 15. Lung Cancer. 2012. PMID: 22704426 Clinical Trial.
41 results